[1] BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling

[2] PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas

[3] Association of the APC gene product with beta-catenin

[4] Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells

[5] Wnt/beta-catenin signaling in development and disease

[6] Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor

[7] Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice

[8] A common human skin tumour is caused by activating mutations in beta-catenin

[9] Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limb

[10] The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer

[11] Functional interaction of beta-catenin with the transcription factor LEF-1

[12] Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas